Get the top three things to know in women's health + wellness, every weekday:

estrogen, but make it scarce

Hear are the trends we spotted this week in women’s health, and as always, scroll for the top clicked stories.

  • ⚠️ Abortion bans linked to rising postpartum depression. Comparing outcomes before and after the Supreme Court overturned Roe, researchers found a 9% increase in postpartum depression among low-income women in states that banned abortion. The data adds to growing evidence that abortion bans affect women’s health well beyond pregnancy itself.

  • 💊 Menopause demand is outpacing supply. Increased use of hormone therapy, helped along by recent FDA label changes, has contributed to nationwide shortages of estrogen patches. It’s a reminder that demand can move faster than manufacturing and access, even as menopause care draws more investment.

  • 🩺 Cervical cancer screening may be able to scale back. A study found that women vaccinated against HPV might need fewer Pap smears over a lifetime. This comes soon after the FDA approved self-swab tests for cervical cancer, showing how prevention strategies could quickly evolve.


TOP CLICKED STORIES THIS WEEK

Menopause myths, debunked // National Geographic

Postpartum depression rose after abortion bans, study finds // JAMA Network Open

NIH funding cuts disrupt breast cancer research pipeline // American College of Physicians

Estrogen patch shortage leaves patients scrambling // ABC7

Pregnant and undocumented, avoiding care out of fear // The New York Times

Midi Health hits unicorn status with $100M raise // Fierce Healthcare